Tempus is a technology company that has built an operating system to battle cancer. The company enables physicians to deliver personalized cancer care for patients through its interactive analytical and machine learning platform. Tempus provides genomic sequencing services and analyzes molecular and therapeutic data to empower physicians to make real-time, data-driven decisions. The company also offers research services to enable discovery of new therapeutic targets and clinical services that support clinical trial design and monitoring. Tempus was founded in 2015 by Eric Lefkofsky and has raised over $8 billion in funding to date.